Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1988 1
1991 1
1994 3
1995 1
1996 2
1998 2
2000 1
2001 1
2003 1
2004 1
2006 1
2007 1
2008 10
2009 11
2010 4
2011 3
2012 5
2013 4
2014 2
2015 10
2017 1
2019 1
2020 1
2022 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Simões EAF, Esser MT, Khan AA, Dubovsky F, Villafana T, DeVincenzo JP; Nirsevimab Study Group. Griffin MP, et al. N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556. N Engl J Med. 2020. PMID: 32726528 Clinical Trial.
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
Domachowske J, Madhi SA, Simões EAF, Atanasova V, Cabañas F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D, Chang Y, Leach A, Takas T, Yuan Y, Griffin MP, Mankad VS, Villafana T; MEDLEY Study Group. Domachowske J, et al. N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186. N Engl J Med. 2022. PMID: 35235733 Clinical Trial. No abstract available.
Measles.
Arguedas AG, Deveikis AA, Marks MI. Arguedas AG, et al. Among authors: deveikis aa. Am J Infect Control. 1991 Dec;19(6):290-8. doi: 10.1016/0196-6553(91)90175-c. Am J Infect Control. 1991. PMID: 1763825 Review.
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.
Colbers A, Best B, Schalkwijk S, Wang J, Stek A, Hidalgo Tenorio C, Hawkins D, Taylor G, Kreitchmann R, Burchett S, Haberl A, Kabeya K, van Kasteren M, Smith E, Capparelli E, Burger D, Mirochnick M; PANNA Network and the IMPAACT 1026 Study Team. Colbers A, et al. Clin Infect Dis. 2015 Nov 15;61(10):1582-9. doi: 10.1093/cid/civ587. Epub 2015 Jul 22. Clin Infect Dis. 2015. PMID: 26202768 Free PMC article. Clinical Trial.
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.
Winter HS, Oleske JM, Hughes MD, McKinney RE Jr, Elgie C, Powell C, Purdue L, Puga AM, Jimenez E, Scott GB, Cruz ML, Moye J Jr; Pediatric AIDS Clinical Trials Group Protocol 247 Study Team. Winter HS, et al. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):222-32. doi: 10.1097/MPG.0b013e3181928937. J Pediatr Gastroenterol Nutr. 2009. PMID: 19543114 Free PMC article. Clinical Trial.
A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, Steinberg SP, Bartlett P; Pediatric AIDS Clinical Trials Group 391 Team. Gershon AA, et al. Pediatr Infect Dis J. 2009 Jul;28(7):653-5. doi: 10.1097/INF.0b013e3181998f06. Pediatr Infect Dis J. 2009. PMID: 19561431 Free PMC article. Clinical Trial.
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA 3rd, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A; IMPAACT P1047 Protocol Team. Levin MJ, et al. J Acquir Immune Defic Syndr. 2010 Oct;55(2):197-204. doi: 10.1097/QAI.0b013e3181de8d26. J Acquir Immune Defic Syndr. 2010. PMID: 20574412 Free PMC article. Clinical Trial.
The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19.
Gottlieb RL, Clement M, Cook P, Deveikis A, Foong KS, Robinson P, Slim J, Spak CW, Buelens A, Callewaert K, De Meyer S, Mo WL, Verbrugge I, Van Wesenbeeck L, Zhuang Y, Chien JW, Opsomer M, Van Landuyt E. Gottlieb RL, et al. Among authors: deveikis a. J Infect. 2024 Oct;89(4):106241. doi: 10.1016/j.jinf.2024.106241. Epub 2024 Sep 2. J Infect. 2024. PMID: 39182655 Free article. Clinical Trial.
69 results